CDC Panel Chooses Pfizer And Moderna Over J&J Due To Blood Clots

The side effects from the J&J COVID vaccine were looked at by a CDC panel.

They voted unanimously that adults seeking boosters should go with Pfizer or Moderna vaccine rather than Johnson & Johnson vaccine.

From Zero Hedge:

A panel of health advisors to the Centers for Disease Control and Prevention voted Thursday unanimously that adults seeking boosters should go with Pfizer-BioNTech or Moderna vaccine rather than Johnson & Johnson vaccine.

The Advisory Committee on Immunization Practices voted 15-0 that the mRNA vaccines are “preferred” to the J&J vaccine because they’re the safest and most effective vaccines.

CDC Director Rochelle Walensky is expected to decide whether to adopt the panel’s advice as agency policy later today.

Johnson & Johnson’s COVID-19 vaccine has been linked to rare forms of blood clotting.

Key Point:

This isn’t the CDC finally taking COVID vax adverse reactions seriously. This is another example of how Pfizer and Moderna seem to have the favor of the government.

We can’t forget Pfizer waited until after election day to announce their vaccine.

The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions. You can help us beat Big Tech by following us on GETTR , Telegram, and Rumble.

CLICK TO SUPPORT US AND BUY OUR SHIRTS

We appreciate feedback. Click here to send us any comments and corrections. 

Listen to our Daily News Podcast!

Share Your Thoughts

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.